• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微血管病变在糖尿病性心肌病中的作用。

Role of microangiopathy in diabetic cardiomyopathy.

机构信息

Institute of Cardiovascular Sciences, Department of Physiology, Faculty of Medicine, University of Manitoba, St. Boniface Hospital Research, 351 Tache Avenue, Winnipeg, MB, R2H 2A6, Canada.

出版信息

Heart Fail Rev. 2014 Jan;19(1):25-33. doi: 10.1007/s10741-013-9378-7.

DOI:10.1007/s10741-013-9378-7
PMID:23456446
Abstract

Although heart disease due to diabetes is mainly associated with complications of the large vessels, microvascular abnormalities are also considered to be involved in altering cardiac structure and function. Three major defects, such as endothelial dysfunction, alteration in the production/release of hormones, and shift in metabolism of smooth muscle cells, have been suggested to produce damage to the small arteries and capillaries (microangiopathy) due to hyperglycemia, and promote the development of diabetic cardiomyopathy. These factors may either act alone or in combination to produce oxidative stress as well as changes in cellular signaling and gene transcription, which in turn cause vasoconstriction and structural remodeling of the coronary vessels. Such alterations in microvasculature produce hypoperfusion of the myocardium and thereby lower the energy status resulting in changes in Ca(2+)-handling, apoptosis, and decreased cardiac contractile force. This article discusses diabetes-induced mechanisms of microvascular damage leading to cardiac dysfunction that is characterized by myocardial dilatation, cardiac hypertrophy as well as early diastolic and late systolic defects. Metabolic defects and changes in neurohumoral system due to diabetes, which promote disturbances in vascular homeostasis, are highlighted. In addition, increase in the vulnerability of the diabetic heart to the development of heart failure and the signaling pathways integrating nuclear factor κB and protein kinase C in diabetic cardiomyopathy are also described for comparison.

摘要

尽管糖尿病引起的心脏病主要与大血管并发症有关,但微血管异常也被认为参与了心脏结构和功能的改变。由于高血糖,三种主要的缺陷,如内皮功能障碍、激素产生/释放的改变以及平滑肌细胞代谢的转移,被认为会导致小动脉和毛细血管(微血管病变)受损,并促进糖尿病心肌病的发展。这些因素可能单独或联合作用产生氧化应激以及细胞信号转导和基因转录的变化,进而导致冠状动脉血管的收缩和结构重塑。微血管的这种改变导致心肌灌注不足,从而降低能量状态,导致 Ca(2+)-处理、细胞凋亡和心肌收缩力下降的变化。本文讨论了糖尿病引起的微血管损伤导致心脏功能障碍的机制,其特征是心肌扩张、心脏肥大以及早期舒张和晚期收缩缺陷。强调了由于糖尿病导致的代谢缺陷和神经激素系统的变化,促进了血管内稳态的紊乱。此外,还描述了糖尿病心脏对心力衰竭发展的易感性增加以及整合核因子 κB 和蛋白激酶 C 的信号通路,以便进行比较。

相似文献

1
Role of microangiopathy in diabetic cardiomyopathy.微血管病变在糖尿病性心肌病中的作用。
Heart Fail Rev. 2014 Jan;19(1):25-33. doi: 10.1007/s10741-013-9378-7.
2
Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice.芦丁可缓解糖尿病心肌病,并改善糖尿病载脂蛋白 E 基因敲除小鼠的心脏功能。
Eur J Pharmacol. 2017 Nov 5;814:151-160. doi: 10.1016/j.ejphar.2017.08.023. Epub 2017 Aug 19.
3
Oxidative stress and diabetic cardiomyopathy: a brief review.氧化应激与糖尿病性心肌病:简要综述
Cardiovasc Toxicol. 2001;1(3):181-93. doi: 10.1385/ct:1:3:181.
4
Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.葡萄糖诱导的细胞信号在糖尿病心肌病发病机制中的作用。
Heart Fail Rev. 2014 Jan;19(1):75-86. doi: 10.1007/s10741-013-9381-z.
5
Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.糖尿病性心脏病的分子机制——实验研究进展。
Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt B):1949-1959. doi: 10.1016/j.bbadis.2017.10.035. Epub 2017 Nov 3.
6
An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.糖尿病心肌病中炎症过程与代谢紊乱的相互作用概述。
Int J Cardiol. 2013 Oct 9;168(4):3160-72. doi: 10.1016/j.ijcard.2013.07.150. Epub 2013 Aug 6.
7
Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism.胰高血糖素样肽-1 通过 cAMP/PKA/Rho 依赖机制保护糖尿病心脏微血管免受损伤。
Diabetes. 2013 May;62(5):1697-708. doi: 10.2337/db12-1025. Epub 2013 Jan 30.
8
An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy.糖尿病心肌病发病机制中心肌炎症信号转导机制概述。
Cardiovasc Res. 2017 Mar 15;113(4):378-388. doi: 10.1093/cvr/cvx011.
9
EGFR inhibition protects cardiac damage and remodeling through attenuating oxidative stress in STZ-induced diabetic mouse model.表皮生长因子受体抑制通过减轻 STZ 诱导的糖尿病小鼠模型中的氧化应激来保护心脏损伤和重构。
J Mol Cell Cardiol. 2015 May;82:63-74. doi: 10.1016/j.yjmcc.2015.02.029. Epub 2015 Mar 7.
10
Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy.叉头框转录因子1:在糖尿病性心肌病发病机制中的作用
Cardiovasc Diabetol. 2016 Mar 8;15:44. doi: 10.1186/s12933-016-0361-1.

引用本文的文献

1
Influence of fluctuations in fasting blood glucose on left ventricular function in patients with type 2 diabetes mellitus and coronary microcirculation dysfunction: a prospective cohort study.空腹血糖波动对2型糖尿病合并冠状动脉微循环功能障碍患者左心室功能的影响:一项前瞻性队列研究。
Acta Diabetol. 2025 May 7. doi: 10.1007/s00592-025-02514-2.
2
G protein regulation by RGS proteins in the pathophysiology of dilated cardiomyopathy.RGS蛋白在扩张型心肌病病理生理学中对G蛋白的调节作用
Am J Physiol Heart Circ Physiol. 2025 Feb 1;328(2):H348-H360. doi: 10.1152/ajpheart.00653.2024. Epub 2025 Jan 7.
3
Single nucleotide polymorphisms: Implications in the early diagnosis and targeted intervention of coronary microvascular dysfunction.

本文引用的文献

1
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.《2012年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》:欧洲心脏病学会2012年急性和慢性心力衰竭诊断与治疗特别工作组编著。与欧洲心脏病学会心力衰竭协会(HFA)合作制定。
Eur Heart J. 2012 Jul;33(14):1787-847. doi: 10.1093/eurheartj/ehs104. Epub 2012 May 19.
2
Oxidative stress and diabetic complications.氧化应激与糖尿病并发症。
Circ Res. 2010 Oct 29;107(9):1058-70. doi: 10.1161/CIRCRESAHA.110.223545.
3
单核苷酸多态性:对冠状动脉微血管功能障碍早期诊断及靶向干预的意义
Genes Dis. 2024 Feb 28;12(2):101249. doi: 10.1016/j.gendis.2024.101249. eCollection 2025 Mar.
4
Cardiometabolic Index is associated with heart failure: a cross-sectional study based on NHANES.心脏代谢指数与心力衰竭相关:一项基于美国国家健康与营养检查调查(NHANES)的横断面研究。
Front Med (Lausanne). 2024 Dec 9;11:1507100. doi: 10.3389/fmed.2024.1507100. eCollection 2024.
5
Insulin-Heart Axis: Bridging Physiology to Insulin Resistance.胰岛素-心脏轴:连接生理学与胰岛素抵抗。
Int J Mol Sci. 2024 Jul 31;25(15):8369. doi: 10.3390/ijms25158369.
6
Association of non-insulin-based insulin resistance indices with disease severity and adverse outcome in idiopathic pulmonary arterial hypertension: a multi-center cohort study.非胰岛素相关胰岛素抵抗指标与特发性肺动脉高压疾病严重程度和不良结局的相关性:一项多中心队列研究。
Cardiovasc Diabetol. 2024 May 3;23(1):154. doi: 10.1186/s12933-024-02236-9.
7
The double burden: type 1 diabetes and heart failure-a comprehensive review.双重负担:1 型糖尿病与心力衰竭——全面综述。
Cardiovasc Diabetol. 2024 Feb 12;23(1):65. doi: 10.1186/s12933-024-02136-y.
8
Fatty acid β-oxidation and mitochondrial fusion are involved in cardiac microvascular endothelial cell protection induced by glucagon receptor antagonism in diabetic mice.脂肪酸β-氧化和线粒体融合参与了胰高血糖素受体拮抗剂在糖尿病小鼠心脏微血管内皮细胞保护中的作用。
J Diabetes. 2023 Dec;15(12):1081-1094. doi: 10.1111/1753-0407.13458. Epub 2023 Aug 19.
9
Association between Severity of Diabetic Retinopathy and Cardiac Function in Patients with Type 2 Diabetes.2 型糖尿病患者糖尿病视网膜病变严重程度与心脏功能的关系。
J Diabetes Res. 2023 Jun 7;2023:6588932. doi: 10.1155/2023/6588932. eCollection 2023.
10
Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus.精氨酸脱羧酶抑制剂在 2 型糖尿病微血管并发症发病机制中的作用。
Front Endocrinol (Lausanne). 2023 Apr 21;14:1183586. doi: 10.3389/fendo.2023.1183586. eCollection 2023.
Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition.
内皮细胞衍生的内皮素-1 通过刺激内皮细胞向间充质转化促进糖尿病心脏中的心肌纤维化。
Circulation. 2010 Jun 8;121(22):2407-18. doi: 10.1161/CIRCULATIONAHA.110.938217. Epub 2010 May 24.
4
Activation of protein kinase C isoforms and its impact on diabetic complications.蛋白激酶 C 同工型的激活及其对糖尿病并发症的影响。
Circ Res. 2010 Apr 30;106(8):1319-31. doi: 10.1161/CIRCRESAHA.110.217117.
5
Endothelial dysfunction as a target for prevention of cardiovascular disease.内皮功能障碍作为预防心血管疾病的靶点。
Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S314-21. doi: 10.2337/dc09-S330.
6
Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease.应激性心脏病中循环儿茶酚胺和糖皮质激素过量的作用。
Can J Physiol Pharmacol. 2009 Jul;87(7):493-514. doi: 10.1139/y09-042.
7
Anti-atherosclerotic molecules targeting oxidative stress and inflammation.靶向氧化应激和炎症的抗动脉粥样硬化分子。
Curr Pharm Des. 2009;15(27):3094-107. doi: 10.2174/138161209789058048.
8
The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues.糖尿病组织中缺氧诱导的VEGF表达受损的分子基础。
Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13505-10. doi: 10.1073/pnas.0906670106. Epub 2009 Jul 28.
9
Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.亚硝化应激在糖尿病血管功能障碍发病机制中的作用。
Br J Pharmacol. 2009 Mar;156(5):713-27. doi: 10.1111/j.1476-5381.2008.00086.x. Epub 2009 Feb 6.
10
The importance of endothelin-1 for microvascular dysfunction in diabetes.内皮素-1在糖尿病微血管功能障碍中的重要性。
Vasc Health Risk Manag. 2008;4(5):1061-8. doi: 10.2147/vhrm.s3920.